Gradiant vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Gradiant

LeaderWater Tech

Industrial Water Treatment

Unicorn valuation ($1B+). $50M debt from HSBC (Oct 2025). 1,300 employees. Serves TSMC, Coca-Cola, and Pfizer with proprietary water treatment at enterprise scale.

About

Gradiant is a water technology unicorn providing advanced industrial water treatment solutions to semiconductor fabs, pharmaceutical manufacturers, and food and beverage companies. The company closed a $50 million debt round in October 2025 with HSBC as first-time investor, reflecting its unicorn valuation and the growing institutional finance interest in water infrastructure as a climate-resilient asset class.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.